kr375.70
2.81% today
Copenhagen, Oct 07, 04:59 pm CET
ISIN
DK0062498333
Symbol
NOVO B

Novo Nordisk Stock price

kr375.70
+28.75 8.29% 1M
-58.35 13.44% 6M
-248.50 39.81% YTD
-427.70 53.24% 1Y
-21.95 5.52% 3Y
+158.58 73.03% 5Y
+195.85 108.90% 10Y
+343.85 1,079.59% 20Y
Copenhagen, Closing price Tue, Oct 07 2025
-10.85 2.81%
ISIN
DK0062498333
Symbol
NOVO B
Industry

Key metrics

Basic
Market capitalization
kr1.7t
Enterprise Value
kr1.8t
Net debt
kr80.3b
Cash
kr18.9b
Shares outstanding
4.4b
Valuation (TTM | estimate)
P/E
15.5 | 15.6
P/S
5.4 | 5.3
EV/Sales
5.7 | 5.5
EV/FCF
28.6
P/B
10.0
Dividends
DPS
kr11.40
Yield 1Y | 5Y
3.0% | 1.6%
Growth 1Y | 5Y
21.3% | 22.3%
Payout 1Y | 3Y
50.4% | 50.5%
Increased
18 Years
Financials (TTM | estimate)
Revenue
kr311.9b | kr318.8b
EBITDA
kr158.8b | kr155.8b
EBIT
kr142.8b | kr138.5b
Net Income
kr111.1b | kr109.7b
Free Cash Flow
kr61.6b
Growth (TTM | estimate)
Revenue
20.9% | 9.8%
EBITDA
18.1% | 9.6%
EBIT
21.9% | -0.3%
Net Income
23.5% | 8.6%
Free Cash Flow
-6.7%
Margin (TTM | estimate)
Gross
84.0%
EBITDA
50.9% | 48.9%
EBIT
45.8%
Net
35.6% | 34.4%
Free Cash Flow
19.8%
Financial Health
Equity Ratio
30.8%
Return on Equity
70.4%
ROCE
52.0%
ROIC
42.1%
Debt/Equity
0.6
More
EPS
kr25.0
FCF per Share
kr13.9
Short interest
-
Employees
77k
Rev per Employee
kr3.8m
Show more

Is Novo Nordisk a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Novo Nordisk Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Novo Nordisk forecast:

18x Buy
60%
10x Hold
33%
2x Sell
7%

Analyst Opinions

30 Analysts have issued a Novo Nordisk forecast:

Buy
60%
Hold
33%
Sell
7%

Financial data from Novo Nordisk

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
311,938 311,938
21% 21%
100%
- Direct Costs 50,068 50,068
25% 25%
16%
261,870 261,870
20% 20%
84%
- Selling and Administrative Expenses 71,834 71,834
14% 14%
23%
- Research and Development Expense 45,288 45,288
20% 20%
15%
158,810 158,810
18% 18%
51%
- Depreciation and Amortization 16,011 16,011
7% 7%
5%
EBIT (Operating Income) EBIT 142,799 142,799
22% 22%
46%
Net Profit 111,068 111,068
24% 24%
36%

In millions DKK.

Don't miss a Thing! We will send you all news about Novo Nordisk directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Novo Nordisk Stock News

AD HOC NEWS
20 days ago
Aktien des dänischen Pharmakonzerns Novo Nordisk DK0062498333 haben am Donnerstag deutlich zugelegt.
AD HOC NEWS
21 days ago
Die Privatbank Berenberg hat Novo Nordisk DK0062498333 von "Hold" auf "Buy" hochgestuft, das Kursziel aber von 610 auf 425 dänische Kronen gesenkt.
AD HOC NEWS
28 days ago
Das US-Analysehaus Bernstein Research hat die Einstufung für Novo Nordisk DK0062498333 von "Market-Perform" auf "Outperform" hochgestuft, das Kursziel aber von 620 auf 540 dänische Kronen gesenkt.
More Novo Nordisk News

Company Profile

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Head office Denmark
CEO Lars Jørgensen
Employees 76,826
Founded 1931
Website www.novonordisk.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today